Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
May Health logo — We are bringing a modern approach to the treatment of PCOS w...

May Health

We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment.

Founded 2017 France France 30 employees Series B Total: $33.00M Health Care, Medical Devices

General Information

Company Name May Health
Founded Year 2017
Location France France
Employees 30
Industries Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with May Health. To contact May Health, visit mayhealth.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does May Health compare?

A PDF of May Health and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting May Health soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About May Health

May Health is a France-based startup, formerly known as AblaCare, with a focus on revolutionizing the treatment of PCOS. Their mission is encapsulated in the slogan, "We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment." Founded in 2017, May Health operates within the Health Care and Medical Devices industries. The company recently secured a notable €23.00M Series B investment on 13 May 2024, with the backing of key investors including Avestria Ventures, Bpifrance, Sofinnova Partners, Trill Impact, and Kidron. May Health's innovative approach and substantial investment indicate a promising trajectory in the development of their investigational Ovarian Rebalancing Treatment.

Business keywords: Women's Health, Fertility Treatment, PCOS Therapy, Medical Innovation, Minimally Invasive Procedures, Reproductive Health, Fertility Solutions, HealthTech, Innovative Therapies

Services & Products

Development of investigational treatment for Polycystic Ovary Syndrome
Clinical trials for Ovarian Rebalancing

Target Customers

Patients with Polycystic Ovary Syndrome Healthcare professionals involved in PCOS treatment and management

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €23.00M 5
Avestria Ventures Bpifrance Sofinnova Partners
Avestria Ventures, Bpifrance +3
13 May 2024
Series A €10.00M 1
Sofinnova Partners
Sofinnova Partners
09 Jul 2019
Seed Round Undisclosed 1
MedTech Innovator
MedTech Innovator
17 Sep 2018

May Health Alternatives & Competitors

View All Alternatives
May Health vs
The Stork Ib2C, A Rinovum Women's Health Company
The Stork Ib2C, A Rinovum Women's Health Company United States

The Stork Ib2C, A Rinovum Women’s Health Company is a women’s health company dedicated to bringing p...

Series C
3 employees
Health Care, Medical Devices
May Health vs
Béa Fertility
Béa Fertility United Kingdom

Startup building the first clinical grade fertility treatment | Increasing access to effective and a...

Venture round
16 employees
Health Care, Health and Wellness
May Health vs
Mirabilis Medical
Mirabilis Medical

Pioneering non-invasive solutions for treating uterine fibroids, empowering gynecologists to heal wi...

Debt Financing
Health Care, Health and Wellness
Also compare with: May Health vs Femasys Inc. Femasys Inc. May Health vs Vertos Medical Vertos Medical View all alternatives

FAQ About May Health

We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment.
May Health was founded in 2017.
May Health is headquartered in France.
May Health operates in Health Care and Medical Devices. Its work centres on Women's Health, Fertility Treatment, PCOS Therapy and Medical Innovation. Its customers include Patients with Polycystic Ovary Syndrome and Healthcare professionals involved in PCOS treatment and management.
May Health has approximately 30 employees.
May Health has completed 3 funding rounds, raising a total of $33.00M. The latest funding stage is Series B.
May Health offers: Development of investigational treatment for Polycystic Ovary Syndrome, Clinical trials for Ovarian Rebalancing.
Top alternatives and competitors to May Health include The Stork Ib2C, A Rinovum Women's Health Company, Béa Fertility, Mirabilis Medical, Shady Grove Fertility, Femasys Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
May Health and The Stork Ib2C, A Rinovum Women's Health Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for May Health, https://bouncewatch.com/company/may-health, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout